Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) Correction (v197,p395) Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Schuler-Thurner, B. Articles by Schuler, G. Search for Related Content PubMed PubMed Citation Articles by Schuler-Thurner, B. Articles by Schuler, G. Social Bookmarking                      What's this?

¹ Department of Dermatology, University Hospital of Erlangen, D-91052 Erlangen, Germany
² Department of Dermatology, University of Innsbruck, A-6020 Innsbruck, Austria

Address correspondence to Gerold Schuler, Dept. of Dermatology, University Hospital of Erlangen, Hartmannstr. 14, D-91052 Erlangen, Germany. Phone: 49-9131-85-1006; Fax: 49-9131-85-6175; E-mail: schuler{at}derma.imed.uni-erlangen.de

There is consensus that an optimized cancer vaccine will have to induce not only CD8⁺ cytotoxic but also CD4⁺ T helper (Th) cells, particularly interferon (IFN)-–producing, type 1 Th cells. The induction of strong, ex vivo detectable type 1 Th cell responses has not been reported to date. We demonstrate now that the subcutaneous injection of cryopreserved, mature, antigen-loaded, monocyte-derived dendritic cells (DCs) rapidly induces unequivocal Th1 responses (ex vivo detectable IFN-–producing effectors as well as proliferating precursors) both to the control antigen KLH and to major histocompatibility complex (MHC) class II–restricted tumor peptides (melanoma-antigen [Mage]-3.DP4 and Mage-3.DR13) in the majority of 16 evaluable patients with metastatic melanoma. These Th1 cells recognized not only peptides, but also DCs loaded with Mage-3 protein, and in case of Mage-3DP4–specific Th1 cells IFN- was released even after direct recognition of viable, Mage-3–expressing HLA-DP4⁺ melanoma cells. The capacity of DCs to rapidly induce Th1 cells should be valuable to evaluate whether Th1 cells are instrumental in targeting human cancer and chronic infections.

Key Words: dendritic cells • vaccination • CD4⁺ T cells • T helper cells • tumor immunity

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Jasny, E., Eisenblatter, M., Matz-Rensing, K., Tenner-Racz, K., Tenbusch, M., Schrod, A., Stahl-Hennig, C., Moos, V., Schneider, T., Racz, P., Uberla, K., Kaup, F.-J., Ignatius, R. (2008). IL-12-Impaired and IL-12-Secreting Dendritic Cells Produce IL-23 upon CD154 Restimulation. J. Immunol. 180: 6629-6639 [Abstract] [Full Text]  
• Zimmermann, V. S., Casati, A., Schiering, C., Caserta, S., Michelini, R. H., Basso, V., Mondino, A. (2007). Tumors Hamper the Immunogenic Competence of CD4+ T Cell-Directed Dendritic Cell Vaccination. J. Immunol. 179: 2899-2909 [Abstract] [Full Text]  
• Chan, W. K., Wai Law, H. K., Lin, Z.-B., Lau, Y. L., Chan, G. C.-F. (2007). Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley. Int Immunol 0: dxm061v1- [Abstract] [Full Text]  
• Perez-Diez, A., Joncker, N. T., Choi, K., Chan, W. F. N., Anderson, C. C., Lantz, O., Matzinger, P. (2007). CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 109: 5346-5354 [Abstract] [Full Text]  
• Thurnher, M. (2007). Lipids in dendritic cell biology: messengers, effectors, and antigens. J. Leukoc. Biol. 81: 154-160 [Abstract] [Full Text]  
• Lesimple, T., Neidhard, E.-M., Vignard, V., Lefeuvre, C., Adamski, H., Labarriere, N., Carsin, A., Monnier, D., Collet, B., Clapisson, G., Birebent, B., Philip, I., Toujas, L., Chokri, M., Quillien, V. (2006). Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients. Clin. Cancer Res. 12: 7380-7388 [Abstract] [Full Text]  
• Hoene, V., Peiser, M., Wanner, R. (2006). Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19. J. Leukoc. Biol. 80: 1328-1336 [Abstract] [Full Text]  
• Yagi, H., Hashizume, H., Horibe, T., Yoshinari, Y., Hata, M., Ohshima, A., Ito, T., Takigawa, M., Shibaki, A., Shimizu, H., Seo, N. (2006). Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous Peptide immunization.. Cancer Res. 66: 10136-10144 [Abstract] [Full Text]  
• Li, H., Wojciechowski, W., Dell'Agnola, C., Lopez, N. E., Espinoza-Delgado, I. (2006). IFN-{gamma} and T-bet Expression in Human Dendritic Cells from Normal Donors and Cancer Patients Is Controlled through Mechanisms Involving ERK-1/2-Dependent and IL-12-Independent Pathways. J. Immunol. 177: 3554-3563 [Abstract] [Full Text]  
• Schott, M. (2006). Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.. Endocr Relat Cancer 13: 779-795 [Abstract] [Full Text]  
• Wierecky, J., Muller, M. R., Wirths, S., Halder-Oehler, E., Dorfel, D., Schmidt, S. M., Hantschel, M., Brugger, W., Schroder, S., Horger, M. S., Kanz, L., Brossart, P. (2006). Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients. Cancer Res. 66: 5910-5918 [Abstract] [Full Text]  
• Fukuyama, T., Hanagiri, T., Takenoyama, M., Ichiki, Y., Mizukami, M., So, T., Sugaya, M., So, T., Sugio, K., Yasumoto, K. (2006). Identification of a New Cancer/Germline Gene, KK-LC-1, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung Adenocarcinoma.. Cancer Res. 66: 4922-4928 [Abstract] [Full Text]  
• Cohen, W. M., Pouvelle-Moratille, S., Wang, X.-F., Farci, S., Munier, G., Charron, D., Menez, A., Busson, M., Maillere, B. (2006). Scanning the HIV Genome for CD4+ T Cell Epitopes Restricted to HLA-DP4, the Most Prevalent HLA Class II Molecule. J. Immunol. 176: 5401-5408 [Abstract] [Full Text]  
• Butterfield, L. H., Ribas, A., Dissette, V. B., Lee, Y., Yang, J. Q., De la Rocha, P., Duran, S. D., Hernandez, J., Seja, E., Potter, D. M., McBride, W. H., Finn, R., Glaspy, J. A., Economou, J. S. (2006). A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four {alpha}-Fetoprotein Peptides.. Clin. Cancer Res. 12: 2817-2825 [Abstract] [Full Text]  
• Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Brocker, E.-B., Grabbe, S., Rittgen, W., Edler, L., Sucker, A., Zimpfer-Rechner, C., Berger, T., Kamarashev, J., Burg, G., Jonuleit, H., Tuttenberg, A., Becker, J. C., Keikavoussi, P., Kampgen, E., Schuler, G. (2006). Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol 17: 563-570 [Abstract] [Full Text]  
• Trumpfheller, C., Finke, J. S., Lopez, C. B., Moran, T. M., Moltedo, B., Soares, H., Huang, Y., Schlesinger, S. J., Park, C. G., Nussenzweig, M. C., Granelli-Piperno, A., Steinman, R. M. (2006). Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203: 607-617 [Abstract] [Full Text]  
• Dao, T., Gomez-Nunez, M., Antczak, C., Kappel, B., Singh Jaggi, J., Korontsvit, T., Zakhaleva, V., Scheinberg, D. A. (2005). Natural Killer Cells License Dendritic Cell Cross-Presentation of B Lymphoma Cell-Associated Antigens. Clin. Cancer Res. 11: 8763-8772 [Abstract] [Full Text]  
• Breckpot, K., Corthals, J., Bonehill, A., Michiels, A., Tuyaerts, S., Aerts, C., Heirman, C., Thielemans, K. (2005). Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell response. J. Leukoc. Biol. 78: 898-908 [Abstract] [Full Text]  
• Moran, T. P., Collier, M., McKinnon, K. P., Davis, N. L., Johnston, R. E., Serody, J. S. (2005). A Novel Viral System for Generating Antigen-Specific T Cells. J. Immunol. 175: 3431-3438 [Abstract] [Full Text]  
• Bertho, N., Adamski, H., Toujas, L., Debove, M., Davoust, J., Quillien, V. (2005). Efficient migration of dendritic cells toward lymph node chemokines and induction of TH1 responses require maturation stimulus and apoptotic cell interaction. Blood 106: 1734-1741 [Abstract] [Full Text]  
• de Vries, I. J. M., Bernsen, M. R., Lesterhuis, W. J., Scharenborg, N. M., Strijk, S. P., Gerritsen, M.-J. P., Ruiter, D. J., Figdor, C. G., Punt, C. J.A., Adema, G. J. (2005). Immunomonitoring Tumor-Specific T Cells in Delayed-Type Hypersensitivity Skin Biopsies After Dendritic Cell Vaccination Correlates With Clinical Outcome. JCO 23: 5779-5787 [Abstract] [Full Text]  
• Rossi, M., Young, J. W. (2005). Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity. J. Immunol. 175: 1373-1381 [Abstract] [Full Text]  
• Tang, J., Flomenberg, P., Harshyne, L., Kenyon, L., Andrews, D. W. (2005). Glioblastoma Patients Exhibit Circulating Tumor-Specific CD8+ T Cells. Clin. Cancer Res. 11: 5292-5299 [Abstract] [Full Text]  
• Dieckmann, D., Schultz, E. S., Ring, B., Chames, P., Held, G., Hoogenboom, H. R., Schuler, G. (2005). Optimizing the exogenous antigen loading of monocyte-derived dendritic cells. Int Immunol 17: 621-635 [Abstract] [Full Text]  
• Schaft, N., Dorrie, J., Thumann, P., Beck, V. E., Muller, I., Schultz, E. S., Kampgen, E., Dieckmann, D., Schuler, G. (2005). Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation. J. Immunol. 174: 3087-3097 [Abstract] [Full Text]  
• Zhang, Y., Sun, Z., Nicolay, H., Meyer, R. G., Renkvist, N., Stroobant, V., Corthals, J., Carrasco, J., Eggermont, A. M. M., Marchand, M., Thielemans, K., Wolfel, T., Boon, T., van der Bruggen, P. (2005). Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein. J. Immunol. 174: 2404-2411 [Abstract] [Full Text]  
• Germeau, C., Ma, W., Schiavetti, F., Lurquin, C., Henry, E., Vigneron, N., Brasseur, F., Lethe, B., De Plaen, E., Velu, T., Boon, T., Coulie, P. G. (2005). High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. J. Exp. Med. 201: 241-248 [Abstract] [Full Text]  
• Cloosen, S., Thio, M., Vanclee, A., van Leeuwen, E. B. M., Senden-Gijsbers, B. L. M. G., Oving, E. B. H., Germeraad, W. T. V., Bos, G. M. J. (2004). Mucin-1 is expressed on dendritic cells, both in vitro and in vivo. Int Immunol 16: 1561-1571 [Abstract] [Full Text]  
• O'Neill, D. W., Adams, S., Bhardwaj, N. (2004). Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104: 2235-2246 [Abstract] [Full Text]  
• Di Nicola, M., Carlo-Stella, C., Mortarini, R., Baldassari, P., Guidetti, A., Gallino, G. F., Del Vecchio, M., Ravagnani, F., Magni, M., Chaplin, P., Cascinelli, N., Parmiani, G., Gianni, A. M., Anichini, A. (2004). Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell Vaccination: A Phase I Trial in Metastatic Melanoma. Clin. Cancer Res. 10: 5381-5390 [Abstract] [Full Text]  
• Wong, R., Lau, R., Chang, J., Kuus-Reichel, T., Brichard, V., Bruck, C., Weber, J. (2004). Immune Responses to a Class II Helper Peptide Epitope in Patients with Stage III/IV Resected Melanoma. Clin. Cancer Res. 10: 5004-5013 [Abstract] [Full Text]  
• Mocellin, S., Wang, E., Panelli, M., Pilati, P., Marincola, F. M. (2004). DNA Array-Based Gene Profiling in Tumor Immunology. Clin. Cancer Res. 10: 4597-4606 [Abstract] [Full Text]  
• Avigan, D., Vasir, B., Gong, J., Borges, V., Wu, Z., Uhl, L., Atkins, M., Mier, J., McDermott, D., Smith, T., Giallambardo, N., Stone, C., Schadt, K., Dolgoff, J., Tetreault, J.-C., Villarroel, M., Kufe, D. (2004). Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses. Clin. Cancer Res. 10: 4699-4708 [Abstract] [Full Text]  
• Nencioni, A., Brossart, P. (2004). Cellular Immunotherapy with Dendritic Cells in Cancer: Current Status. Stem Cells 22: 501-513 [Abstract] [Full Text]  
• Bonehill, A., Heirman, C., Tuyaerts, S., Michiels, A., Breckpot, K., Brasseur, F., Zhang, Y., van der Bruggen, P., Thielemans, K. (2004). Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules. J. Immunol. 172: 6649-6657 [Abstract] [Full Text]  
• Schag, K., Schmidt, S. M., Muller, M. R., Weinschenk, T., Appel, S., Weck, M. M., Grunebach, F., Stevanovic, S., Rammensee, H.-G., Brossart, P. (2004). Identification of C-Met Oncogene as a Broadly Expressed Tumor-Associated Antigen Recognized by Cytotoxic T-Lymphocytes. Clin. Cancer Res. 10: 3658-3666 [Abstract] [Full Text]  
• Rouas, R., Lewalle, P., El Ouriaghli, F., Nowak, B., Duvillier, H., Martiat, P. (2004). Poly(I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12. Int Immunol 16: 767-773 [Abstract] [Full Text]  
• Stift, A., Sachet, M., Yagubian, R., Bittermann, C., Dubsky, P., Brostjan, C., Pfragner, R., Niederle, B., Jakesz, R., Gnant, M., Friedl, J. (2004). Dendritic Cell Vaccination in Medullary Thyroid Carcinoma. Clin. Cancer Res. 10: 2944-2953 [Abstract] [Full Text]  
• Hanson, H. L., Kang, S. S., Norian, L. A., Matsui, K., O'Mara, L. A., Allen, P. M. (2004). CD4-Directed Peptide Vaccination Augments an Antitumor Response, but Efficacy Is Limited by the Number of CD8+ T Cell Precursors. J. Immunol. 172: 4215-4224 [Abstract] [Full Text]  
• Movassagh, M., Spatz, A., Davoust, J., Lebecque, S., Romero, P., Pittet, M., Rimoldi, D., Lienard, D., Gugerli, O., Ferradini, L., Robert, C., Avril, M.-F., Zitvogel, L., Angevin, E. (2004). Selective Accumulation of Mature DC-Lamp+ Dendritic Cells in Tumor Sites Is Associated with Efficient T-Cell-Mediated Antitumor Response and Control of Metastatic Dissemination in Melanoma. Cancer Res. 64: 2192-2198 [Abstract] [Full Text]  
• Atanackovic, D., Altorki, N. K., Stockert, E., Williamson, B., Jungbluth, A. A., Ritter, E., Santiago, D., Ferrara, C. A., Matsuo, M., Selvakumar, A., Dupont, B., Chen, Y.-T., Hoffman, E. W., Ritter, G., Old, L. J., Gnjatic, S. (2004). Vaccine-Induced CD4+ T Cell Responses to MAGE-3 Protein in Lung Cancer Patients. J. Immunol. 172: 3289-3296 [Abstract] [Full Text]  
• Gyobu, H., Tsuji, T., Suzuki, Y., Ohkuri, T., Chamoto, K., Kuroki, M., Miyoshi, H., Kawarada, Y., Katoh, H., Takeshima, T., Nishimura, T. (2004). Generation and Targeting of Human Tumor-Specific Tc1 and Th1 Cells Transduced with a Lentivirus Containing a Chimeric Immunoglobulin T-Cell Receptor. Cancer Res. 64: 1490-1495 [Abstract] [Full Text]  
• Palmowski, M. J., Lopes, L., Ikeda, Y., Salio, M., Cerundolo, V., Collins, M. K. (2004). Intravenous Injection of a Lentiviral Vector Encoding NY-ESO-1 Induces an Effective CTL Response. J. Immunol. 172: 1582-1587 [Abstract] [Full Text]  
• Schultz, E. S., Schuler-Thurner, B., Stroobant, V., Jenne, L., Berger, T. G., Thielemanns, K., van der Bruggen, P., Schuler, G. (2004). Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy. J. Immunol. 172: 1304-1310 [Abstract] [Full Text]  
• Brown, K., Gao, W., Alber, S., Trichel, A., Murphey-Corb, M., Watkins, S. C., Gambotto, A., Barratt-Boyes, S. M. (2003). Adenovirus-Transduced Dendritic Cells Injected into Skin or Lymph Node Prime Potent Simian Immunodeficiency Virus-Specific T Cell Immunity in Monkeys. J. Immunol. 171: 6875-6882 [Abstract] [Full Text]  
• Goldszmid, R. S., Idoyaga, J., Bravo, A. I., Steinman, R., Mordoh, J., Wainstok, R. (2003). Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma. J. Immunol. 171: 5940-5947 [Abstract] [Full Text]  
• Karanikas, V., Lurquin, C., Colau, D., van Baren, N., De Smet, C., Lethe, B., Connerotte, T., Corbiere, V., Demoitie, M.-A., Lienard, D., Dreno, B., Velu, T., Boon, T., Coulie, P. G. (2003). Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus. J. Immunol. 171: 4898-4904 [Abstract] [Full Text]  
• Wissniowski, T. T., Hansler, J., Neureiter, D., Frieser, M., Schaber, S., Esslinger, B., Voll, R., Strobel, D., Hahn, E. G., Schuppan, D. (2003). Activation of Tumor-specific T Lymphocytes by Radio-Frequency Ablation of the VX2 Hepatoma in Rabbits. Cancer Res. 63: 6496-6500 [Abstract] [Full Text]  
• Bonehill, A., Heirman, C., Tuyaerts, S., Michiels, A., Zhang, Y., van der Bruggen, P., Thielemans, K. (2003). Efficient Presentation of Known HLA Class II-restricted MAGE-A3 Epitopes by Dendritic Cells Electroporated with Messenger RNA Encoding an Invariant Chain with Genetic Exchange of Class II-associated Invariant Chain Peptide. Cancer Res. 63: 5587-5594 [Abstract] [Full Text]  
• Xu, S., Koski, G. K., Faries, M., Bedrosian, I., Mick, R., Maeurer, M., Cheever, M. A., Cohen, P. A., Czerniecki, B. J. (2003). Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism. J. Immunol. 171: 2251-2261 [Abstract] [Full Text]  
• Fujii, S.-i., Shimizu, K., Smith, C., Bonifaz, L., Steinman, R. M. (2003). Activation of Natural Killer T Cells by {alpha}-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein. J. Exp. Med. 198: 267-279 [Abstract] [Full Text]  
• Zhang, Y., Chaux, P., Stroobant, V., Eggermont, A. M. M., Corthals, J., Maillere, B., Thielemans, K., Marchand, M., Boon, T., van der Bruggen, P. (2003). A MAGE-3 Peptide Presented by HLA-DR1 to CD4+ T Cells That Were Isolated from a Melanoma Patient Vaccinated with a MAGE-3 Protein. J. Immunol. 171: 219-225 [Abstract] [Full Text]  
• Santini, S. M., Belardelli, F. (2003). Advances in the Use of Dendritic Cells and New Adjuvants for the Development of Therapeutic Vaccines. Stem Cells 21: 495-505 [Abstract] [Full Text]  
• Flynn, S., Stockinger, B. (2003). Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation. Blood 101: 4472-4478 [Abstract] [Full Text]  
• Su, Z., Dannull, J., Heiser, A., Yancey, D., Pruitt, S., Madden, J., Coleman, D., Niedzwiecki, D., Gilboa, E., Vieweg, J. (2003). Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells. Cancer Res. 63: 2127-2133 [Abstract] [Full Text]  
• Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., Padera, R., Jaklitsch, M. T., Shankar, S., Chen, T. C., Korman, A., Allison, J. P., Dranoff, G. (2003). Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl. Acad. Sci. USA 100: 4712-4717 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS